Previous Article | Next Article ![]()
Journal of Bacteriology, April 2007, p. 2618-2628, Vol. 189, No. 7
0021-9193/07/$08.00+0 doi:10.1128/JB.01905-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Karen A. Vigeant,1,
,
Laura D. Tatar,1 and
Miguel A. Valvano1,2*
Infectious Diseases Research Group, Siebens-Drake Medical Research Institute, Departments of Microbiology and Immunology,1 Medicine, University of Western Ontario, London, Ontario N6A 5C1, Canada2
Received 18 December 2006/ Accepted 15 January 2007
WecA is an integral membrane protein that initiates the biosynthesis of enterobacterial common antigen and O-antigen lipopolysaccharide (LPS) by catalyzing the transfer of N-acetylglucosamine (GlcNAc)-1-phosphate onto undecaprenyl phosphate (Und-P) to form Und-P-P-GlcNAc. WecA belongs to a large family of eukaryotic and prokaryotic prenyl sugar transferases. Conserved aspartic acids in putative cytoplasmic loops 2 (Asp90 and Asp91) and 3 (Asp156 and Asp159) were targeted for replacement mutagenesis with either glutamic acid or asparagine. We examined the ability of each mutant protein to complement O-antigen LPS synthesis in a wecA-deficient strain and also determined the steady-state kinetic parameters of the mutant proteins in an in vitro transfer assay. Apparent Km and Vmax values for UDP-GlcNAc, Mg2+, and Mn2+ suggest that Asp156 is required for catalysis, while Asp91 appears to interact preferentially with Mg2+, possibly playing a role in orienting the substrates. Topological analysis using the substituted cysteine accessibility method demonstrated the cytosolic location of Asp90, Asp91, and Asp156 and provided a more refined overall topological map of WecA. Also, we show that cells expressing a WecA derivative C terminally fused with the green fluorescent protein exhibited a punctate distribution of fluorescence on the bacterial surface, suggesting that WecA localizes to discrete regions in the bacterial plasma membrane.
Published ahead of print on 19 January 2007.
J.L. and K.A.V. contributed equally to this work.
Present address: Bioniche Life Sciences Inc., Belleville, ON K8N 1E2, Canada.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»